A detailed history of Strategic Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Strategic Asset Management, LLC holds 25 shares of MRNA stock, worth $1,643. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$1,643
Previous $4,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$225.82 - $368.51 $4,516 - $7,370
-20 Reduced 44.44%
25 $6,000
Q3 2021

Nov 04, 2021

BUY
$221.9 - $484.47 $9,985 - $21,801
45 New
45 $14,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.